Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Leukemia, Myeloid, Acute 68Leukemia 56Myelodysplastic Syndromes 53Lymphoma 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 46Lymphoma, Non-Hodgkin 43Multiple Myeloma 40Hodgkin Disease 39Leukemia, Lymphocytic, Chronic, B-Cell 35Congenital Abnormalities 30Lymphoma, Follicular 28Lymphoma, Large B-Cell, Diffuse 27Lymphoma, Mantle-Cell 26Neoplasms, Plasma Cell 25Lymphoma, B-Cell, Marginal Zone 24Leukemia, Myelogenous, Chronic, BCR-ABL Positive 23Burkitt Lymphoma 23Myeloproliferative Disorders 22Lymphoma, Large-Cell, Immunoblastic 22Leukemia, Myelomonocytic, Chronic 22Blast Crisis 22Leukemia, Myeloid, Chronic-Phase 21Leukemia, Myeloid, Accelerated Phase 21Primary Myelofibrosis 19Lymphoma, T-Cell, Cutaneous 15Hematologic Neoplasms 15Graft vs Host Disease 15Dendritic Cell Sarcoma, Interdigitating 14Anemia, Refractory, with Excess of Blasts 14Waldenstrom Macroglobulinemia 13

Interventions

Doxorubicin 33Ifosfamide 23Gemcitabine 19pazopanib 18Cyclophosphamide 16Radiotherapy 15pembrolizumab 13Filgrastim 12Docetaxel 12Bevacizumab 10Vincristine 9Sirolimus 9Irinotecan 9Etoposide 9olaratumab 7eribulin 7Sorafenib 7Radiation 7temsirolimus 6Temozolomide 6Mesna 6Magnetic Resonance Spectroscopy 6Cisplatin 6tazemetostat 5cixutumumab 5Trabectedin 5Radiosurgery 5Nivolumab 5Ipilimumab 5Granulocyte Colony-Stimulating Factor 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Sarcoma × Busulfan × Clear all
NCT00357396 2015-11-25

Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
10 enrolled 7 charts
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡